A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback